Evidence map›Paper›PMID 31936124›Full record

ArticleBiomolecules2020

Cell Penetrating Peptide as a High Safety Anti-Inflammation Ingredient for Cosmetic Applications.

Tse-Kai Fu, Ping-Hsueh Kuo, Yen-Chang Lu, Hsing-Ni Lin, Lily Hui-Ching Wang, Yu-Chun Lin, Yu-Chen Kao, Huey-Min Lai, Margaret Dah-Tsyr Chang

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Tse-Kai FuInstitute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu 30013, Taiwan.
Ping-Hsueh KuoInstitute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu 30013, Taiwan.
Yen-Chang LuInstitute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu 30013, Taiwan.
Hsing-Ni LinInstitute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu 30013, Taiwan.
Lily Hui-Ching WangInstitute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu 30013, Taiwan.
Yu-Chun LinIndustrial Technology Research Institute, Hsinchu 30011, Taiwan.
Yu-Chen KaoIndustrial Technology Research Institute, Hsinchu 30011, Taiwan.
Huey-Min LaiIndustrial Technology Research Institute, Hsinchu 30011, Taiwan.
Margaret Dah-Tsyr ChangInstitute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu 30013, Taiwan.
National Tsing Hua University · TWIndustrial Technology Research Institute · TWSimpson Biotech Company (Taiwan) · TW

Funding

Industrial Value Creation Program for Academia 108B7016V1Ministry of Science and Technology H456GB1530Ministry of Science and Technology H456GB1550Ministry of Science and Technology MOST 107-0210-01-19-04Program for Translational Innovation of Biopharmaceutical Development-Technology Supporting Platform Axis AS-KPQ-108-TSPA
6 · The paper itself

Abstract

Cosmeceutical peptides have become an important topic in recent decades in both academic and industrial fields. Many natural or synthetic peptides with different biological functions including anti-ageing, anti-oxidation, anti-infection and anti-pigmentation have been developed and commercialized. Current cosmeceutical peptides have already satisfied most market demand, remaining: "cargos carrying skin penetrating peptide with high safety" still an un-met need. To this aim, a cell-penetrating peptide, CPP

Indexed as

AnimalsAnti-Inflammatory AgentsCell-Penetrating PeptidesCosmeceuticalsCosmeticsDrug Delivery SystemsHumansModels, BiologicalSkinAnti-Inflammatory AgentsCell-Penetrating PeptidesCosmeceuticalsCosmeticsanti-inflammationcell-penetrating peptidescosmeceutical peptides

Identifiers

PMID31936124
PMCPMC7023394
OpenAlexW2999201783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.